Mirum Pharmaceuticals, Inc. Prepaid Expense and Other Assets, Current
Mirum Pharmaceuticals, Inc. (MIRM) had Prepaid Expense and Other Assets, Current of $26.89 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-05
- 2026-06-30: Prepaid Expense and Other Assets, Current $26.89M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $24.55M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $18.14M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $23.87M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $26.89M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $24.55M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $18.14M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $23.87M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $19.07M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $14.87M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $11.78M 10-K · filed 2026-02-25 |
| 2024-09-30 | $12.06M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $8.59M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $10.02M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $10.94M 10-K · filed 2025-02-26 |
| 2023-09-30 | $12.46M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $9.73M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $8.99M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $8.95M 10-K · filed 2024-03-15 |
| 2022-09-30 | $6.93M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $3.78M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $5.91M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $5.27M 10-K · filed 2023-03-08 |
| 2021-09-30 | $6.37M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $4.51M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $4.64M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $4.53M 10-K · filed 2022-03-09 |
| 2020-09-30 | $4.40M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.74M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.90M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.70M 10-K · filed 2021-03-09 |
| 2019-09-30 | $3.06M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $666.00K 10-Q · filed 2019-08-28 |
| 2018-12-31 | $12.00K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |